Analyst consensus rating
Bausch Health Companies Analyst Rating: Hold
BHC is rated Hold by 5 analysts with a $7.50 target. As of 2026-08-31.
Direct answer
Bausch Health Companies's consensus rating is Hold.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $7.50.
Forecast evidence checked August 31, 2026.
Get free Bausch Health Companies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $6.32
- Average price target
- $7.50
- High price target
- $9.00
- Low price target
- $6.50
- Low target gap
- +2.8%
- Target upside
- +18.7%
- High target gap
- +42.4%
- Target range width
- 39.6%
- Consensus rating
- Hold
- Analysts
- 5
- Evidence date
- August 31, 2026
- Valid through
- September 7, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Bausch Health Companies?
Bausch Health Companies has a verified Hold consensus. The same dataset has an average price target of $7.50.
How far are Bausch Health Companies's low and high targets from the recorded price?
The low target implies +2.8%, while the high target implies +42.4%.
How many analysts are included in Bausch Health Companies's consensus?
The verified consensus includes 5 analysts.
How is Bausch Health Companies's target upside or downside calculated?
The average target of $7.50 is divided by the recorded price of $6.32, then one is subtracted to produce +18.7%. This does not guarantee a future return.
When was Bausch Health Companies's analyst forecast verified?
The data was verified on 2026-08-31. The dataset is valid through 2026-09-07.